New publication ! JAMA Psychiatry
Association Between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion
Our new study, using the Quebec Pregnancy Cohort, reports an association between first trimester benzodiazepine use and an increased risk of spontaneous abortion.
It's not just any bensodiazepine!
The risk was not significantly different among pregnancies exposed to short-acting and long-acting benzodiazepine agents. On the other hand, the association between benzodiazepines and spontaneous abortion was strengthened with increasing diazepam-equivalent daily doses.
Find the full publication at JAMA Psychiatry
New publications in the Canadian Medical Association Journal!
The new publication of the Medication and Pregnancy team, based on data from the Quebec Pregnancy Cohort, reports that exposure to fluconazole, an oral antifungal, during the first trimester of pregnancy is associated with an increase in risk of miscarriage. In addition, taking higher doses of fluconazole (over 150 mg) in early pregnancy may be associated with an increased risk of having a newborn with a cardiac malformation.
To read the summary click here.
PhD Defense - Ms. Takoua Boukhris
Our doctoral candidate in the pharmaceutical sciences, Mrs. Takoua Boukhris, will be defending her thesis on Tuesday, December 11 at 3:00 pm in Room 2199 of the Jean Coutu Pavilion, Université de Montréal.
Her thesis, titled Use of Antidepressant Drugs During Pregnancy and the Risk of Autism Spectrum Disorder and Attention Deficit Disorder with and without hyperactivity in children, is an impact work that has led to more than 10 publications. and many presentations.
Does Risk of Embryonic Malformations Outweigh Benefits of Using SSRIs in Pregnant Women with Depression?
In a comprehensive new review article Dr Anick Bérard et al. present the most current understanding of the role selective serotonin reuptake inhibitors (SSRIs) play in increased risk of multiple diverse gestational malformations and take aim at the ongoing debate over whether SSRIs as a drug class can cause these malformations. The article, which also highlights the importance of serotonin - a key mediator of bioelectric control mechanisms - in normal embryonic development, is published in the preview issue of Bioelectricity. Click here